Howe & Rusling Inc Editas Medicine, Inc. Transaction History

Howe & Rusling Inc

  • $1.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$12.16 - $19.42 $2,432 - $3,884
-200 Reduced 88.89%
25 $0
Q2 2022

Aug 15, 2022
BUY
$9.99 - $21.35 $2,247 - $4,803
225 New
225 $3,000
Q4 2020

Feb 08, 2021
SELL
$27.07 - $84.35 $6,767 - $21,087
-250 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$28.06 - $37.16 $7,015 - $9,290
250 New
250 $7,000

Others Institutions Holding EDIT

# of Institutions
250
Shares Held
57.1M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $92.1M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email